160 results on '"Sachdeva, Kuldeep Singh"'
Search Results
2. Assessing the impact of COVID-19 management on the workload of human resources working in India’s National Tuberculosis Elimination Program
3. Active case finding for tuberculosis in India: A syntheses of activities and outcomes reported by the national tuberculosis elimination programme
4. Building communities of practice through case-based e-learning to prevent and manage TB among people living with HIV–India
5. Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets
6. 75th National Conference of tuberculosis and chest diseases: DR KS Sachdeva Speech
7. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial
8. Test and Treat Model for Tuberculosis Preventive Treatment among Household Contacts of Pulmonary Tuberculosis Patients in Selected Districts of Maharashtra: A Mixed-Methods Study on Care Cascade, Timeliness, and Early Implementation Challenges
9. Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial
10. Assessing tuberculosis control priorities in high-burden settings: a modelling approach
11. A Retrospective Study of Characteristics of HIV Infected Individuals Opting Out from Antiretroviral Treatment under National Programme
12. Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research
13. Assessing the impact of COVID-19 management on the workload of human resources working in India’s National Tuberculosis Elimination Program
14. Early Prognostication in Retreatment Pulmonary Tuberculosis patients by serum soluble TREM-1 levels
15. Closing the gaps in tuberculosis detection—considerations for policy makers
16. Nutritional Supplementation to Prevent TB Incidence in Household-Contacts of Patients with Pulmonary Tuberculosis: Results from the RATIONS, a Field-Based Open-Label Cluster-Randomized Controlled Trial in Jharkhand, India
17. Innovatively addressing the challenge of maintaining binocular microscopes under Tuberculosis Programme in India – Is this feasible?
18. Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data
19. Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries ‐ a systematic review and meta‐analysis
20. Building communities of practice through case-based e-learning to prevent and manage TB among people living with HIV–India
21. Baseline Assessments of TB Diagnostic Centers in Selected Public and Private Centers in India and Need for Introducing Quality Management Systems
22. Active Case Finding for Tuberculosis in India: A Syntheses of Activities and Outcomes Reported by the National Tuberculosis Elimination Programme
23. Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates—Chennai, India, 2013–2016
24. Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020)
25. How do patients who fail first-line TB treatment but who are not placed on an MDR-TB regimen fare in South India?
26. TB free India by 2025: hype or hope
27. What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India
28. Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India
29. Evaluation of key survey components of bio-behavioral surveillance among HIV high-risk subpopulation in Western India.
30. Insights in Tuberculosis Immunology: Role of NKT and T Regulatory Cells.
31. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): Evidence leading to policy enhancement
32. TB free India by 2025: hype or hope.
33. New Vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - 'Reaching the un-reached'
34. Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis
35. Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda
36. Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis
37. Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population
38. How do patients who fail first-line TB treatment but who are not placed on an MDR-TB regimen fare in South India?
39. Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India
40. The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis
41. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India
42. Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in India
43. Alarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, India
44. Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
45. Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India
46. LED-Fluorescence Microscopy for Diagnosis of Pulmonary Tuberculosis under Programmatic Conditions in India
47. Is One Sputum Specimen as Good as Two during Follow-Up Cultures for Monitoring Multi Drug Resistant Tuberculosis Patients in India?
48. How Did the TB Patients Reach DOTS Services in Delhi? A Study of Patient Treatment Seeking Behavior
49. Operational Challenges in Diagnosing Multi-Drug Resistant TB and Initiating Treatment in Andhra Pradesh, India
50. Source of Previous Treatment for Re-Treatment TB Cases Registered under the National TB Control Programme, India, 2010
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.